José de León

22.5k total citations · 1 hit paper
414 papers, 14.9k citations indexed

About

José de León is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, José de León has authored 414 papers receiving a total of 14.9k indexed citations (citations by other indexed papers that have themselves been cited), including 240 papers in Psychiatry and Mental health, 62 papers in Clinical Psychology and 60 papers in Pharmacology. Recurrent topics in José de León's work include Schizophrenia research and treatment (175 papers), Bipolar Disorder and Treatment (71 papers) and Pharmacogenetics and Drug Metabolism (60 papers). José de León is often cited by papers focused on Schizophrenia research and treatment (175 papers), Bipolar Disorder and Treatment (71 papers) and Pharmacogenetics and Drug Metabolism (60 papers). José de León collaborates with scholars based in United States, Spain and China. José de León's co-authors include Francisco J. Díaz, Edoardo Spina, Margaret T. Susce, Manuel J. Cuesta, Víctor Peralta, Enrique Baca‐García, George M. Simpson, María J. Arranz, Pilar A. Sáiz and Richard C. Josiassen and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and American Journal of Psychiatry.

In The Last Decade

José de León

401 papers receiving 14.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors

2005 965 citations José de León et al. Schizophrenia Research profile →

Peers

Countries citing papers authored by José de León

Since Specialization

Citations

This map shows the geographic impact of José de León's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José de León with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José de León more than expected).

Fields of papers citing papers by José de León

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José de León. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José de León. The network helps show where José de León may publish in the future.

Co-authorship network of co-authors of José de León

This figure shows the co-authorship network connecting the top 25 collaborators of José de León. A scholar is included among the top collaborators of José de León based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José de León. José de León is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Clozapine-treated patients and myocardial infarction in adults: a pharmacovigilance study in VigiBase interpreted in the context of the literature	Expert Opinion on Drug Safety	Carlos De las Cuevas, Emílio J. Sanz et al.	2
2	Fatal Outcomes in Use of Clozapine	Journal of Clinical Psychopharmacology	Carlos De las Cuevas, Emílio J. Sanz et al.	1
3	Correlation between low sleep satisfaction and death wish in a three-month Ecological Momentary Assessment study	PubMed	Francisco J. Díaz, María Luisa Barrigón et al.	3
4	Investigating in VigiBase over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia	Expert Opinion on Drug Metabolism & Toxicology	José de León, Can‐Jun Ruan et al.	10
5	Pharmacovigilance in Action: Utilizing VigiBase Data to Improve Clozapine Safety	Patient Preference and Adherence	Carlos De las Cuevas, Emílio J. Sanz et al.	8
6	A Chinese medicine called Danggui Longhui may be a new clinically relevant clozapine inducer: Two case reports identified by therapeutic drug monitoring	Schizophrenia Research	Can‐Jun Ruan, Qi Yang et al.	2
7	Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK	Schizophrenia Research	Carlos De las Cuevas, Emílio J. Sanz et al.	10
8	Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: Comparing the top four reporting countries (US, UK, Canada and Australia)	Schizophrenia Research	Carlos De las Cuevas, Emílio J. Sanz et al.	22
9	Will ChatGPT3 Substitute for us as Clozapine Experts?	Journal of Clinical Psychopharmacology	José de León, Carlos De las Cuevas	2
10	Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database	Schizophrenia Research	Renato de Filippis, Carlos De las Cuevas et al.	8
11	Valproate, obesity and other causes of clozapine poor metabolism in the context of rapid titration may explain clozapine-induced myocarditis: A re-analysis of a Turkish case series	Revista de Psiquiatría y Salud Mental (English Edition)	Aygün Ertuğrul, A. Elif Anıl Yağcıoğlu et al.	6
12	Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countries	Revista de Psiquiatría y Salud Mental	Carlos De las Cuevas, Emílio J. Sanz et al.	35
13	Adherence to psychiatric medications: Comparing patients with schizophrenia, bipolar disorder and major depression.	PubMed	Judit Lazáry, Carlos De las Cuevas et al.	7
14	Effect of necessity‐concern framework and polypharmacy on treatment adherence in psychiatric patients. Comparing an Argentinian with a Spanish sample	Human Psychopharmacology Clinical and Experimental	Carlos De las Cuevas, Alejandro Villasante‐Tezanos et al.	2
15	<p>Self-Report for Measuring and Predicting Medication Adherence: Experts’ Experience in Predicting Adherence in Stable Psychiatric Outpatients and in Pharmacokinetics</p>	Patient Preference and Adherence	Carlos De las Cuevas, José de León	8
16	The necessity‐concern framework in the assessment of treatment adherence of psychiatric patients and the role of polypharmacy in a Spanish sample	Human Psychopharmacology Clinical and Experimental	Carlos De las Cuevas, Moisés Betancort et al.	3
17	Adding Oral Contraceptives to Clozapine May Require Halving the Clozapine Dose	Journal of Clinical Psychopharmacology	Georgios Schoretsanitis, John M. Kane et al.	15
18	Antipsychotic medication exposure, clozapine, and pneumonia: results from a self‐controlled study	Acta Psychiatrica Scandinavica	Christopher Rohde, Dan Siskind et al.	22
19	Ethnopsychopharmacology study of patients' beliefs regarding concerns about and necessity of taking psychiatric medications	Human Psychopharmacology Clinical and Experimental	Carlos De las Cuevas, Trino Baptista et al.	5
20	Two Sudden and Unexpected Deaths of Patients with Schizophrenia Associated with Intramuscular Injections of Antipsychotics and Practice Guidelines to Limit the Use of High Doses of Intramuscular Antipsychotics	Case Reports in Psychiatry	Allen Brenzel, José de León et al.	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact